PTJ
TECX

Paul Tudor Jones’s Tectonic Therapeutic TECX Stock Holding History

Paul Tudor Jones’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,103
Closed -$686K – 1904
2020
Q4 		$686K Buy
+4,103
New +$729K 0.02% 831
2018
Q3 		– Sell
-625
Closed -$214K – 1299
2018
Q2 		$214K Buy
+625
New +$225K 0.01% 904

Other funds holding TECX

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Paul Tudor Jones's TECX Position: Q1 2021 in Review

Paul Tudor Jones sold out of Tectonic Therapeutic (TECX) in Q1 2021, closing a stake of 4,103 shares — an estimated $686K sold.

Paul Tudor Jones first reported a position in TECX in Q2 2018 and held it in 2 quarters. The position peaked at $686K in Q4 2020. 99 funds tracked by Wall St. Rank hold TECX as of Q1 2021.

  • Paul Tudor Jones reported no remaining Tectonic Therapeutic position as of Q1 2021 after selling out during the quarter.
  • Paul Tudor Jones sold 4,103 Tectonic Therapeutic shares in Q1 2021, an estimated $686K.
  • Paul Tudor Jones first reported a position in Tectonic Therapeutic in Q2 2018 and held it in 2 quarters.
  • Paul Tudor Jones's Tectonic Therapeutic position peaked at $686K in Q4 2020.
  • 99 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2021.

Based on Tudor Investment Corp's 13F filing for Q1 2021, filed 17 May 2021.